DeepMed Research

Erasmus University Medical Center

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.

Recruiting

Conditions: Cancer, Hepatocellular

Interventions: Diagnostic Test: GAAD score

First Posted Date: 2024-09-19

Last Posted Date: 2024-09-19

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 1000

Registration Number: NCT06601231

Locations: 🇳🇱
Erasmus MC, Rotterdam, CA, Netherlands

The Effect of Progressive Resistance Exercise Training (PRET) on CVRF in Adults With ID.

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
Hypertension
Hypercholesterolemia
Obesity

Interventions: Other: Progressive resistance exercise training

First Posted Date: 2024-08-30

Last Posted Date: 2024-08-30

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 36

Registration Number: NCT06579898

Locations: 🇳🇱
Amarant, Tilburg, Brabant, Netherlands
🇳🇱
Abrona, Huis Ter Heide, Zuid-holland, Netherlands
🇳🇱
Ipse de Bruggen, Zoetermeer, Zuid-holland, Netherlands

Treatment Frequency Reduction in Pompe Disease

Phase 4

Not yet recruiting

Conditions: Pompe Disease (Late-onset)
Acid Maltase Deficiency
GAA Deficiency
Glycogen Storage Disease Type II

Interventions: Drug: Algucosidase alfa 20 mg/kg once every 4 weeks instead of once every 2 weeks

First Posted Date: 2024-08-28

Last Posted Date: 2024-08-28

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 10

Registration Number: NCT06575829

FCV Vs VCV in Obstructive and Asthmatic Patients

Not Applicable

Recruiting

Conditions: Obstructive Pulmonary Disease
Asthma COPD
Mechanical Ventilation Pressure High

Interventions: Device: FCV

First Posted Date: 2024-08-21

Last Posted Date: 2024-10-18

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 10

Registration Number: NCT06563544

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
🇳🇱
Maasstad Hospital, Rotterdam, Zuid-Holland, Netherlands

The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model

Recruiting

Conditions: Oncology

Interventions: Other: Cancer Admission Score Prediction Model

First Posted Date: 2024-08-16

Last Posted Date: 2025-02-26

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 200

Registration Number: NCT06558487

Locations: 🇳🇱
Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands

Spinal Cord Stimulation for Intractable Mononeuropathy

Not Applicable

Recruiting

Conditions: Spinal Cord Stimulation
Mononeuropathies

Interventions: Device: Spinal cord stimulator

First Posted Date: 2024-08-09

Last Posted Date: 2025-03-03

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 12

Registration Number: NCT06546371

Locations: 🇳🇱
Erasmus Medical Centre, Rotterdam, Zuid-Holland, Netherlands

Preconception Carrier Screening at the Erasmus MC

Recruiting

Conditions: Inherited Genetic Conditions

First Posted Date: 2024-08-09

Last Posted Date: 2024-08-09

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 35

Registration Number: NCT06543784

Locations: 🇳🇱
Erasmus MC, Rotterdam, Netherlands

REMAP ECMO - Beta Receptor Modulation Trial

Phase 2

Recruiting

Conditions: Cardiogenic Shock
Heart Failure

Interventions: Drug: Esmolol

First Posted Date: 2024-07-26

Last Posted Date: 2024-07-26

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 20

Registration Number: NCT06522594

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, Zuid Holland, Netherlands

Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)

Recruiting

Conditions: Vaginal Neoplasms

Interventions: Other: Observational study (Non-interventional study)

First Posted Date: 2024-07-23

Last Posted Date: 2024-07-23

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 300

Registration Number: NCT06514235

Locations: 🇳🇱
Erasmus MC, Rotterdam, Zuid-Holland, Netherlands

a Retrospective Study on the Systemic Treatment of LPP and FFA

Completed

Conditions: Cicatricial Alopecia
Lichen Planopilaris
Lichen Plano-Pilaris
Frontal Fibrosing Alopecia
Hair Diseases
Scarring Alopecia
Hair Loss/Baldness

Interventions: Drug: Hydroxychloroquine
Drug: Methotrexate
Drug: Cyclosporine A
Drug: Retinoids

First Posted Date: 2024-07-22

Last Posted Date: 2024-07-22

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 315

Registration Number: NCT06512766

Locations: 🇳🇱
Erasmus MC, Rotterdam, Zuid-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy